Antibacterial properties of Acinetobacter baumanniiphage Abp1 endolysin (PlyAB1)
暂无分享,去创建一个
Jing Wang | F. Hu | Xiaodong Shen | Xia Zhao | W. Shen | Guangtao Huang | Y. Gong | Zhi-wei Dong | Yizhi Peng | Yi-zhi Peng
[1] D. Paterson,et al. Prevalence of multidrug-resistant organisms and risk factors for carriage in long-term care facilities: a nested case-control study. , 2014, The Journal of antimicrobial chemotherapy.
[2] G. Volckaert,et al. Engineered Endolysin-Based “Artilysins” To Combat Multidrug-Resistant Gram-Negative Pathogens , 2014, mBio.
[3] M. Menéndez,et al. Improving the Lethal Effect of Cpl-7, a Pneumococcal Phage Lysozyme with Broad Bactericidal Activity, by Inverting the Net Charge of Its Cell Wall-Binding Module , 2014, Antimicrobial Agents and Chemotherapy.
[4] Yun-Jaie Choi,et al. Preclinical Safety Evaluation of Intravenously Administered SAL200 Containing the Recombinant Phage Endolysin SAL-1 as a Pharmaceutical Ingredient , 2014, Antimicrobial Agents and Chemotherapy.
[5] Yunsong Yu,et al. Wide distribution of CC92 carbapenem-resistant and OXA-23-producing Acinetobacter baumannii in multiple provinces of China. , 2013, International journal of antimicrobial agents.
[6] N. Suttorp,et al. Delivery of the endolysin Cpl-1 by inhalation rescues mice with fatal pneumococcal pneumonia. , 2013, The Journal of antimicrobial chemotherapy.
[7] M. Menéndez,et al. Improving the Lethal Effect of Cpl-7, a Pneumococcal Phage Lysozyme with Broad Bactericidal Activity, by Inverting the Net Charge of Its Cell Wall-Binding Module , 2013, Antimicrobial Agents and Chemotherapy.
[8] Anren Hu,et al. Identification and characterisation of the putative phage-related endolysins through full genome sequence analysis in Acinetobacter baumannii ATCC 17978. , 2013, International journal of antimicrobial agents.
[9] R. Liddington,et al. The secondary cell wall polysaccharide of Bacillus anthracis provides the specific binding ligand for the C-terminal cell wall-binding domain of two phage endolysins, PlyL and PlyG. , 2013, Glycobiology.
[10] S. Kulakauskas,et al. A Novel Type of Peptidoglycan-binding Domain Highly Specific for Amidated d-Asp Cross-bridge, Identified in Lactobacillus casei Bacteriophage Endolysins* , 2013, The Journal of Biological Chemistry.
[11] P. Su,et al. Identification of a Novel Antimicrobial Peptide from Human Hepatitis B Virus Core Protein Arginine-Rich Domain (ARD) , 2013, PLoS pathogens.
[12] Shuai Le,et al. Characterization and Genome Sequencing of Phage Abp1, a New phiKMV-Like Virus Infecting Multidrug-Resistant Acinetobacter baumannii , 2013, Current Microbiology.
[13] F. Wen,et al. Isolation and Characterization of φkm18p, a Novel Lytic Phage with Therapeutic Potential against Extensively Drug Resistant Acinetobacter baumannii , 2012, PloS one.
[14] M. Loessner,et al. Bacteriophage endolysins as novel antimicrobials. , 2012, Future microbiology.
[15] F. Wen,et al. Isolation and Characterization of phikm18p, a Novel Lytic Phage with Therapeutic Potential against Extensively Drug Resistant Acinetobacter baumannii , 2012 .
[16] F. García-Godoy,et al. Analysis by confocal laser scanning microscopy of the MDPB bactericidal effect on S. mutans biofilm CLSM analysis of MDPB bactericidal effect on biofilm , 2012, Journal of applied oral science : revista FOB.
[17] Anren Hu,et al. Antibacterial activity of Acinetobacter baumannii phage ϕAB2 endolysin (LysAB2) against both Gram-positive and Gram-negative bacteria , 2011, Applied Microbiology and Biotechnology.
[18] T. Tan,et al. In Vitro Antibiotic Synergy in Extensively Drug-Resistant Acinetobacter baumannii: the Effect of Testing by Time-Kill, Checkerboard, and Etest Methods , 2010, Antimicrobial Agents and Chemotherapy.
[19] S. Amyes,et al. Characterization of Epidemiologically Unrelated Acinetobacter baumannii Isolates from Four Continents by Use of Multilocus Sequence Typing, Pulsed-Field Gel Electrophoresis, and Sequence-Based Typing of blaOXA-51-like Genes , 2010, Journal of Clinical Microbiology.
[20] S. Jia,et al. Isolation and Characterization of a Virulent Bacteriophage AB1 of Acinetobacter baumannii , 2010, BMC Microbiology.
[21] M. Adams,et al. Comparative Genome Sequence Analysis of Multidrug-Resistant Acinetobacter baumannii , 2008, Journal of bacteriology.
[22] Harald Seifert,et al. Acinetobacter baumannii: Emergence of a Successful Pathogen , 2008, Clinical Microbiology Reviews.
[23] L. Dijkshoorn,et al. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii , 2007, Nature Reviews Microbiology.
[24] J. Weissenbach,et al. Comparative Genomics of Multidrug Resistance in Acinetobacter baumannii , 2006, PLoS genetics.
[25] F. Rodríguez-Valera,et al. Development of a Multilocus Sequence Typing Scheme for Characterization of Clinical Isolates of Acinetobacter baumannii , 2005, Journal of Clinical Microbiology.
[26] M. Loessner,et al. Bacteriophage endolysins--current state of research and applications. , 2005, Current opinion in microbiology.
[27] P. Jollès,et al. What's new in chitinase research? , 1992, Experientia.
[28] P. von Dippe,et al. Characterization of the bile acid transport system in normal and transformed hepatocytes. Photoaffinity labeling of the taurocholate carrier protein. , 1983, The Journal of biological chemistry.